Alzheimer’s Definitions, Biomarkers, and Antibodies: Halima Amjad, Barak Gaster, and Heather Whitson
March 12, 2026
It’s an era of breakthroughs in Alzheimer’s research, yet for many clinicians, it’s also a time of profound uncertainty. We…
It’s an era of breakthroughs in Alzheimer’s research, yet for many clinicians, it’s also a time of profound uncertainty. We…
Things are changing quickly in the Alzheimer’s space. We now have biomarkers that can reasonably approximate the degree of amyloid…
The US Preventive Services Task Force (USPSTF) concluded back in 2000 that there is insufficient evidence to recommend for or…
There is a growing push to change how we define Alzheimer’s disease from what was historically a clinically defined syndrome…